No progressive brain changes during a 1-year follow-up of patients with first-episode psychosis

Psychological Medicine

Volumn 46, Issue 3, 2016, Pages 589-598

  Haukvik, U K ^a   Hartberg, C B ^a,b   Nerland, S ^a,b   Jorgensen, K N ^a,b   Lange, E H ^a,b   Simonsen, C ^a,c   Nesvag R ^a,b   Dale, A M ^c,d   Andreassen, O A ^a,c   Melle, I ^a,c   Agartz, I ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Key words Bipolar disorder; longitudinal studies; magnetic resonance imaging; schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; BIPOLAR DISORDER; BRAIN CORTEX; CASE CONTROL STUDY; CLINICAL TRIAL; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NORWAY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NORWAY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84961123119     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S003329171500210X     Document Type: Article

References (46)

1. AasM, Haukvik UK, Djurovic S, Bergmann O, Athanasiu L, TesliMS, HellvinT, SteenNE, Agartz I, LorentzenS, Sundet K, AndreassenOA, Melle I (2013). BDNFval66metmodulates theassociationbetweenchildhoodtrauma, cognitiveandbrain abnormalities in psychoses. Progress in Neuro-Psychopharmacology and Biological Psychiatry 46C, 181-188.
2. Agartz I, Shoaf S, Rawlings RR, Momenan R, Hommer DW (2003). CSF monoamine metabolites and MRI brain volumes in alcohol dependence. Psychiatry Research 122, 21-35.
3. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC (2011). Progressive brain change in schizophrenia: A prospective longitudinal study of first-episode schizophrenia. Biological Psychiatry 70, 672-679.
4. Andreassen OA, Thompson WK, Schork AJ, Ripke S, Mattingsdal M, Kelsoe JR, Kendler KS, O'Donovan MC, Rujescu D, Werge T, Sklar P, Roddey JC, Chen CH, McEvoy L, Desikan RS, Djurovic S, Dale AM (2013). Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genetics 9, e1003455.
5. Boonstra G, Cahn W, Schnack HG, Hulshoff Pol HE, Minderhoud TC, Kahn RS, van Haren NE (2011). Duration of untreated illness in schizophrenia is not associated with 5-year brain volume change. Schizophrenia Research 132, 84-90.
6. Cahn W, van Haren NE, Hulshoff Pol HE, Schnack HG, Caspers E, Laponder DA, Kahn RS (2006). Brain volume changes in the first year of illness and 5-year outcome of schizophrenia. British Journal of Psychiatry: The Journal of Mental Science 189, 381-382.
7. Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, Seidman LJ, Tsuang M, Walker E, Woods SW, Heinssen R; North American Prodrome Longitudinal Study Consortium (2015). Progressive reduction in cortical thickness as psychosis develops: A multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biological Psychiatry 77, 147-157.
8. Dale AM, Fischl B, Sereno MI (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. NeuroImage 9, 179-194.
9. Dazzan P, Soulsby B, Mechelli A, Wood SJ, Velakoulis D, Phillips LJ, Yung AR, Chitnis X, Lin A, Murray RM, McGorry PD, McGuire PK, Pantelis C (2012). Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: An MRI study in subjects at ultrahigh risk of psychosis. Schizophrenia Bulletin 38, 1083-1091.
10. Ebdrup BH, Norbak H, Borgwardt S, Glenthoj B (2013). Volumetric changes in the basal ganglia after antipsychotic monotherapy: A systematic review. Current Medicinal Chemistry 20, 438-447.
11. Engh JA, Friis S, Birkenaes AB, Jonsdottir H, Klungsoyr O, Ringen PA, Simonsen C, Vaskinn A, Opjordsmoen S, Andreassen OA (2010). Delusions are associated with poor cognitive insight in schizophrenia. Schizophrenia Bulletin 36, 830-835.
12. Fischl B, SalatDH, Busa E, AlbertM, DieterichM, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, RosenB, DaleAM (2002). Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341-355.
13. Fischl B, Salat DH, van der Kouwe AJ, Makris N, Segonne F, Quinn BT, Dale AM (2004). Sequence-independent segmentation of magnetic resonance images. NeuroImage 23 (Suppl. 1), S69-S84.
14. Fischl B, Sereno MI, Dale AM (1999). Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. NeuroImage 9, 195-207.
15. Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S (2013). Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neuroscience and Biobehavioral Reviews 37, 1680-1691.
16. Gutiérrez-Galve L, Chu EM, Leeson VC, Price G, Barnes TR, Joyce EM, Ron MA (2015). A longitudinal study of cortical changes and their cognitive correlates in patients followed up after first-episode psychosis. Psychological Medicine 45, 205-216.
17. Haukvik UK, McNeil T, Lange EH, Melle I, Dale AM, Andreassen OA, Agartz I (2014). Pre-and perinatal hypoxia associated with hippocampus/amygdala volume in bipolar disorder. Psychological Medicine 44, 975-985.
18. Haukvik UK, Schaer M, Nesvag R, McNeil T, Hartberg CB, Jonsson EG, Eliez S, Agartz I (2012). Cortical folding in Broca's area relates to obstetric complications in schizophrenia patients and healthy controls. Psychological Medicine 42, 1329-1337.
19. Haukvik UK, Westlye LT, Morch-Johnsen L, Jorgensen KN, Lange EH, Dale AM, Melle I, Andreassen OA, Agartz I (2015). In vivo hippocampal subfield volumes in schizophrenia and bipolar disorder. Biological Psychiatry 77, 581-588.
20. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V (2011). Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia. Archives of General Psychiatry 68, 128-137.
21. Hulshoff Pol HE, Kahn RS (2008). What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophrenia Bulletin 34, 354-366.
22. Jorgensen KN, Skjaervo I, Morch-Johnsen L, Haukvik UK, Lange EH, Melle I, Andreassen OA, Agartz I (2015). Cigarette smoking is associated with thinner cingulate and insular cortices in patients with severe mental illness. Journal of Psychiatry and Neuroscience: JPN 40, 241-249.
23. Kahn RS, Sommer IE (2015). The neurobiology and treatment of first-episode schizophrenia. Molecular Psychiatry 20, 84-97.
24. Kay SR, Fiszbein A, Opler LA (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
25. Koo MS, Levitt JJ, Salisbury DF, Nakamura M, Shenton ME, McCarley RW (2008). A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Archives of General Psychiatry 65, 746-760.
26. Lappin JM, Morgan C, Chalavi S, Morgan KD, Reinders AA, Fearon P, Heslin M, Zanelli J, Jones PB, Murray RM, Dazzan P (2014). Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes. Psychological Medicine 44, 1279-1291.
27. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM (2009). Common genetic determinantsof schizophreniaandbipolardisorder inSwedish families: A population-based study. Lancet 373, 234-239.
28. Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T (2013). Cannabis abuse and brainmorphology in schizophrenia: A review of the available evidence. European Archives of Psychiatry and Clinical Neuroscience 263, 3-13.
29. Malchow B, Keeser D, Keller K, Hasan A, Rauchmann BS, Kimura H, Schneider-Axmann T, Dechent P, Gruber O, Ertl-Wagner B, Honer WG, Hillmer-Vogel U, Schmitt A, Wobrock T, Niklas A, Falkai P (2015). Effects of endurance training on brain structures in chronic schizophrenia patients and healthy controls. Schizophrenia Research. Published online 23 January 2015. doi: 10. 1016/j. schres. 2015. 01. 005.
30. Morgan C, Lappin J, Heslin M, Donoghue K, Lomas B, Reininghaus U, Onyejiaka A, Croudace T, Jones PB, Murray RM, Fearon P, Doody GA, Dazzan P (2014). Reappraising the long-term course and outcome of psychotic disorders: The AESOP-10 study. Psychological Medicine 44, 2713-2726.
31. Pope MA, Joober R, Malla AK (2013). Diagnostic stability of first-episode psychotic disorders and persistence of comorbid psychiatric disorders over 1 year. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 58, 588-594.
32. Reuter M, Rosas HD, Fischl B (2010). Highly accurate inverse consistent registration: A robust approach. NeuroImage 53, 1181-1196.
33. Reuter M, Schmansky NJ, Rosas HD, Fischl B (2012). Within-subject template estimation for unbiased longitudinal image analysis. NeuroImage 61, 1402-1418.
34. Rimol LM, Hartberg CB, Nesvag R, Fennema-Notestine C, Hagler Jr. DJ, Pung CJ, Jennings RG, Haukvik UK, Lange E, Nakstad PH, Melle I, Andreassen OA, Dale AM, Agartz I (2010). Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biological Psychiatry 68, 41-50.
35. Rimol LM, Nesvag R, Hagler Jr. DJ, Bergmann O, Fennema-Notestine C, Hartberg CB, Haukvik UK, Lange E, Pung CJ, Server A, Melle I, Andreassen OA, Agartz I, Dale AM (2012). Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biological Psychiatry 71, 552-560.
36. Roiz-Santianez R, Ayesa-Arriola R, Tordesillas-Gutierrez D, Ortiz-Garcia de la Foz V, Perez-Iglesias R, Pazos A, Sanchez E, Crespo-Facorro B (2014). Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients. Psychological Medicine 44, 1591-1604.
37. Salvatore P, BaldessariniRJ, KhalsaHM, AmoreM, DiVittorio C, Ferraro G, Maggini C, TohenM (2013). Predicting diagnostic change among patients diagnosed with firstepisodeDSM-IV-TRmajor depressive disorderwith psychotic features. Journal of Clinical Psychiatry 74, 723-731; quiz 731.
38. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA Jr, Vieta E, Maggini C (2011). McLean-Harvard International First-Episode Project: Two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. Journal of Clinical Psychiatry 72, 183-193.
39. Schaufelberger MS, Lappin JM, Duran FL, Rosa PG, Uchida RR, Santos LC, Murray RM, McGuire PK, Scazufca M, Menezes PR, Busatto GF (2011). Lack of progression of brain abnormalities in first-episode psychosis: A longitudinal magnetic resonance imaging study. Psychological Medicine 41, 1677-1689.
40. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy 3rd FV, Hahn SR, Brody D, Johnson JG (1994). Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA: The Journal of the American Medical Association 272, 1749-1756.
41. Spitzer RL, Williams JBW, Gibbon M, First MB (1992). The Structural Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of General Psychiatry 49, 624-629.
42. van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Brans R, Carati I, Rais M, Kahn RS (2008). Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biological Psychiatry 63, 106-113.
43. Veijola J, Guo JY, Moilanen JS, Jaaskelainen E, Miettunen J, Kyllonen M, Haapea M, Huhtaniska S, Alaraisanen A, Maki P, Kiviniemi V, Nikkinen J, Starck T, Remes JJ, Tanskanen P, Tervonen O, Wink AM, Kehagia A, Suckling J, Kobayashi H, Barnett JH, Barnes A, Koponen HJ, Jones PB, Isohanni M, Murray GK (2014). Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication. PLOS ONE 9, e101689.
44. Vita A, De Peri L, Deste G, Sacchetti E (2012). Progressive loss of cortical gray matter in schizophrenia: A meta-analysis and meta-regression of longitudinal MRI studies. Translational Psychiatry 2, e190.
45. Wang AY, Lohmann KM, Yang CK, Zimmerman EI, Pantazopoulos H, Herring N, Berretta S, Heckers S, Konradi C (2011). Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin-and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathologica 122, 615-626.
46. Zipursky RB, Reilly TJ, Murray RM (2013). The myth of schizophrenia as a progressive brain disease. Schizophrenia Bulletin 39, 1363-1372.